Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery
Biomolecules · 31.05.2025 · 15 (6) · 802
DOI: 10.3390/biom15060802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 31.05.2025. Verfasst von Ramesh Ganpisetti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Terasaki Institute of Biomedical Sciences, 21100 Erwin St, Woodland Hills, Los Angeles, CA 91367-3712, USA. Hauptthemen laut MEDLINE: Neoplasms, Drug Delivery Systems, Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a highly detrimental and fatal illness that poses a significant threat to human well-being. The pattern of cancer treatment is continuously being optimized by the advancement of old treatment approaches and the invention of novel treatment modes. Nanotechnology-based approaches are emerging as powerful candidates in the development of these advanced methods for treating tumors. This article provides a concise overview of nanotechnology for cancer or cancer nanomedicine and its applications. In light of prevalent issues, such as inadequate precision in targeting initial chemotherapy drugs, susceptibility of nucleic acid drugs to degradation, gene delivery, and the occurrence of common immune-related adverse events during immunotherapy, we explore the potential integration of nanomedicine with these treatment approaches and illustrative examples and highlight the benefits that arise from the utilization of nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Terasaki Institute of Biomedical Sciences, 21100 Erwin St, Woodland Hills, Los Angeles, CA 91367-3712, USA.
- Arizona State University, 1151 S. Forest AV Tempe, Tempe, AZ 85281, USA.
- Department of Pharmaceutical Sciences, University of Tennessee Health Science Center (UTHSC), Memphis, TN 38163, USA.
- Department of Ophthalmology and Visual Sciences, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.
- Thermo Fisher Scientific Inc., Cincinnati, OH 45237, USA.
- Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
ORCID-Profile: Sanjay Giridharan, G S Sainaga Jyothi Vaskuri, Pratap Basim, Menekse Ermis, Satish Rojekar, Amol D Gholap, Nagavendra Kommineni
Zitieren
APA
Ganpisetti, R., Giridharan, S., Vaskuri, G. S. S. J., Narang, N., Basim, P., Dokmeci, M. R., Ermis, M., Rojekar, S., Gholap, A. D., & Kommineni, N. (2025). Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery. Biomolecules, 15(6), 802. https://doi.org/10.3390/biom15060802
Vancouver
Ganpisetti R, Giridharan S, Vaskuri GSSJ, Narang N, Basim P, Dokmeci MR, et al. Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery. Biomolecules. 2025;15(6):802. doi:10.3390/biom15060802
BibTeX
@article{Ganpisetti2025,
author = {Ganpisetti, Ramesh and Giridharan, Sanjay and Vaskuri, G S Sainaga Jyothi and Narang, Nikesh and Basim, Pratap and Dokmeci, Mehmet Remzi and Ermis, Menekse and Rojekar, Satish and Gholap, Amol D and Kommineni, Nagavendra},
title = {Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {6},
pages = {802},
doi = {10.3390/biom15060802}
}
EUVIMED